IP Protected Devices Patented corneal implants (Intacs for keratoconus and myopia; AlphaCor artificial cornea; AlphaSphere Orbital Implant) are FDA-cleared and CE-marked, enabling expedited procurement by US and European clinics and creating licensing or exclusive distribution opportunities.

Regulatory Readiness Regulatory clearances reduce risk for buyers; target large ophthalmology networks that prioritize FDA and CE-cleared devices to shorten sales cycles.

Strategic Partnerships As a niche medical device manufacturer, there is scope for distribution agreements, academic collaborations, and contract manufacturing to extend reach and accelerate adoption.

Digital Customer Enablement A modern tech stack supports digital marketing, remote product demonstrations, and streamlined customer support, enabling efficient lead nurturing and post-sale service for clinics.

Channel Growth With a lean team and mid-sized revenue, growth opportunities lie in channel partnerships, surgeon education programs, and expanding into new markets or payer networks for Intacs and AlphaCor.